Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. Juni 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Launches U.S. Sales of its SURE CHECK® HIV 1/2 Assay and Reduces Prices of HIV Tests for U.S. Public Health Market

MEDFORD, N.Y., June 01, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced the launch of U.S....
12. Mai 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports First Quarter 2016 Financial Results

MEDFORD, N.Y., May 12, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today reported financial...
05. Mai 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio and Bio-Manguinhos Announce Plans to Introduce a Point-of-Care Diagnostic Test for Zika Virus in Brazil

MEDFORD, NY, May 05, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced the status of its...
03. Mai 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss First Quarter 2016 Financial Results

MEDFORD, N.Y., May 03, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that the...
25. April 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Awarded Grant to Develop First Oral Fluid/Saliva Point-of-Care Diagnostic Test for Malaria

MEDFORD, N.Y., April 25, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has been awarded a $678,000...
08. März 2016 09:44 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports 2015 Financial Results

MEDFORD, N.Y., March 08, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today reported financial...
07. März 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio to Collaborate With Bio-Manguinhos/Fiocruz to Develop Point-of-Care Zika Diagnostic Tests for Brazil

MEDFORD, N.Y., March 07, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced plans to...
29. Februar 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss 2015 Financial Results

MEDFORD, N.Y., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that...
19. Februar 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Awarded Grant From Paul G. Allen Family Foundation to Develop Point-of-Care Diagnostic Tests for Zika Virus and Related Febrile Illnesses

MEDFORD, N.Y., Feb. 19, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has been awarded a grant from...
26. Januar 2016 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio to Sell Its SURE CHECK® HIV 1/2 Assay in the United States Beginning June 1, 2016

MEDFORD, N.Y., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, will begin selling its SURE...

Vorherige Seite